SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-025172
Filing Date
2020-09-15
Accepted
2020-09-15 20:18:06
Documents
1
Period of Report
2020-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4510
  Complete submission text file 0000899243-20-025172.txt   6056
Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address
LYONS GARY A (Reporting) CIK: 0001123343 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 201177140

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences